Literature DB >> 30906989

Relationship between psoriasis and non-alcoholic fatty liver disease - Updated systematic review and adjusted meta-analysis.

Kevin Phan1,2, James Onggo3, Olivia Charlton4, Saxon D Smith4,5,6.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30906989     DOI： 10.1111/ajd.13015

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


× No keyword cloud information.
  7 in total

Review 1.  Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.

Authors:  F Bellinato; P Gisondi; A Mantovani; G Girolomoni; G Targher
Journal:  J Endocrinol Invest       Date:  2022-02-11       Impact factor: 5.467

2.  Hidradenitis Suppurativa is Associated with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study.

Authors:  Iris González-Villanueva; Cristina DeGracia; Mariana Planells; Inés Poveda; Pedro Álvarez; Luca Schneller-Pavalescu; Isabel Betlloch; Gregor B E Jemec; Jose M Ramos; Jose C Pascual
Journal:  Acta Derm Venereol       Date:  2020-08-18       Impact factor: 3.875

3.  Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients.

Authors:  Isabel Belinchón-Romero; Pablo Bellot; David Romero-Pérez; Isolina Herraiz-Romero; Francisco Marco; Rubén Frances; José-Manuel Ramos-Rincón
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

Review 4.  Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies.

Authors:  Deepak M W Balak; Stefano Piaserico; Ismail Kasujee
Journal:  Psoriasis (Auckl)       Date:  2021-12-07

5.  Bidirectional Association Between Psoriasis and Nonalcoholic Fatty Liver Disease: Real-World Evidence From Two Longitudinal Cohort Studies.

Authors:  Shuo-Yan Gau; Kuang-Hua Huang; Chiu Hsiang Lee; Yu-Hsiang Kuan; Tung-Han Tsai; Chien-Ying Lee
Journal:  Front Immunol       Date:  2022-02-16       Impact factor: 7.561

Review 6.  Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach.

Authors:  Mercedes Perez-Carreras; Begoña Casis-Herce; Raquel Rivera; Inmaculada Fernandez; Pilar Martinez-Montiel; Victoria Villena
Journal:  World J Gastroenterol       Date:  2021-11-07       Impact factor: 5.742

Review 7.  NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.

Authors:  Valerio Rosato; Mario Masarone; Marcello Dallio; Alessandro Federico; Andrea Aglitti; Marcello Persico
Journal:  Int J Environ Res Public Health       Date:  2019-09-14       Impact factor: 3.390
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.